Pemetrexed Injection Generics - Manufacturers & Suppliers
Alimta(EU & US)
| Product/Composition:- | Pemetrexed Injection |
|---|---|
| Strength:- | 100 mg/4 mL vial, 500 mg/20 mL vial |
| Form:- | Injection |
| Reference Brands:- | Alimta(EU & US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Pemetrexed Injection 100 mg/4 mL and 500 mg/20 mL is used to treat non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. Approved in the U.S. and EU under the brand name Alimta, it is a key chemotherapy drug for oncology treatments. Available for IV infusion, it helps slow tumor growth by inhibiting DNA and RNA synthesis.
Pemetrexed Injection 100 mg/4 mL and 500 mg/20 mL is a vital chemotherapy drug used to treat non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. As an IV infusion, Pemetrexed works by inhibiting enzymes crucial for DNA and RNA synthesis, slowing tumor growth. Approved in the U.S. and EU under the brand name Alimta, it is a cornerstone in the treatment of these challenging cancers. With both 100 mg and 500 mg vial strengths, Pemetrexed is crucial for oncology B2B distribution, supporting hospitals and oncology centers in treating advanced lung and mesothelioma cancers.